US Stock MarketDetailed Quotes

CTSO Cytosorbents

Watchlist
  • 0.968
  • +0.101+11.69%
Close May 17 16:00 ET
  • 0.902
  • -0.066-6.78%
Post 19:41 ET
52.55MMarket Cap-1640P/E (TTM)

Cytosorbents Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cytosorbents Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

9.79M

+3.56%
EPS(YoY)

-0.12

+29.41%
Analyst Rating

Hold

Apr 30, 2024

Cytosorbents Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 9.893M--
--2024/Q2-- / 9.735M--
May 9, 20242024/Q19.787M / 9.785M--
Mar 14, 20242023/Q48.668M / 9.840M--
Nov 9, 20232023/Q38.811M / 9.318M--
Aug 1, 20232023/Q29.421M / 10.201M--
May 2, 20232023/Q19.449M / 8.733M--
Mar 9, 20232022/Q49.391M / 8.750M--
Nov 3, 20222022/Q38.111M / 8.519M--
Aug 2, 20222022/Q28.496M / 9.564M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 9.893M--
--2024/Q2-- / 9.735M--
May 9, 20242024/Q19.787M / 9.785M--
Mar 14, 20242023/Q48.668M / 9.840M--
Nov 9, 20232023/Q38.811M / 9.318M--
Aug 1, 20232023/Q29.421M / 10.201M--
May 2, 20232023/Q19.449M / 8.733M--
Mar 9, 20232022/Q49.391M / 8.750M--
Nov 3, 20222022/Q38.111M / 8.519M--
Aug 2, 20222022/Q28.496M / 9.564M--

Unlock Free Earnings Estimates

Cytosorbents Earnings Reports

  • Cytosorbents | 10-Q: Quarterly report

    May 10 05:02

  • Cytosorbents | 10-K: Annual report

    Mar 16 01:21

  • Cytosorbents: Q3 2023 Earnings Report

    Nov 10, 2023 05:10

  • Cytosorbents | 10-Q: Q2 2023 Earnings Report

    Aug 2, 2023 04:13

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 30, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Top Gainers Yesterday
    Top Gainers Yesterday
    Intraday-2.47%